Medicare AdvantageCoverageMedium impact
MA11.014h, Debridement of Mycotic and Symptomatic Non-Mycotic Hypertrophic Toe Nails
Independence Blue Cross·Podiatry, Wound Care, Dermatology·Medical Policy
Effective date
Oct 1, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA11.014h regarding debridement of mycotic and symptomatic non-mycotic hypertrophic toe nails has been updated with new coverage criteria or billing requirements. This affects podiatry and wound care billing procedures for Medicare Advantage plans.
Action Required
By October 1, 2025: Review updated policy MA11.014h for specific changes to debridement procedures for hypertrophic toe nails. Update billing protocols and documentation requirements for mycotic and non-mycotic toe nail debridement procedures for Medicare Advantage patients. Ensure compliance with new coverage criteria to prevent claim denials.